Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17084274 | 0.94 | SIRT2 (0.52) | SIRT2MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL20953490 | 0.87 | PTGS2 (0.49) | SIRT2MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL27805712 | 0.80 | SIRT2 (0.46) | SIRT2MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL22130540 | 0.78 | GABRA1 (0.41) | MAPTALDH1A1KMT2AGAATDP1 | |
| SCHEMBL1879712 | 0.77 | GAA (0.53) | ALDH1A1GAACYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3956144 | 0.77 | GABRA1 (0.48) | MAPTKMT2APKMCYP1A2CYP3A4 | |
| SCHEMBL14931402 | 0.76 | GABRA1 (0.45) | MAPTALDH1A1KMT2APKMCYP1A2 | |
| SCHEMBL14931403 | 0.76 | GABRA1 (0.45) | MAPTALDH1A1KMT2APKMCYP1A2 | |
| SCHEMBL3131974 | 0.74 | SIRT2 (0.50) | SIRT2MAPTALDH1A1KMT2AMEN1 | |
| SCHEMBL3131980 | 0.74 | SIRT2 (0.50) | SIRT2MAPTALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12187823-B2 | Ligand compound, transition metal compound, and catalyst composition including the same | LG CHEM, LTD. (KR) | 2025-01-07 | — | — | US | disclosed |
| EP-3892624-B1 | LIGAND COMPOUND, TRANSITION METAL COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG CHEMICAL LTD (KR) | 2024-09-25 | — | — | EP | disclosed |
| CN-113272310-B | Ligand compound, transition metal compound, and catalyst composition comprising same | LG化学株式会社 | 2024-07-12 | — | — | CN | disclosed |
| US-20220049031-A1 | Ligand Compound, Transition Metal Compound, and Catalyst Composition Including the Same | LG CHEM, LTD. (KR) | 2022-02-17 | — | — | US | disclosed |
| EP-3892624-A1 | LIGAND COMPOUND, TRANSITION METAL COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2021-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220049031-A1 | Ligand Compound, Transition Metal Compound, and Catalyst Composition Including the Same | ICOSLG, OSTC, YAP1 | SIRT2 2202/4885MAPT 2319/4885ALDH1A1 1818/4885 |
| US-12187823-B2 | Ligand compound, transition metal compound, and catalyst composition including the same | ICOSLG, OSTC, YAP1 | SIRT2 2202/4885MAPT 2319/4885ALDH1A1 1818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.